ACI Formulations Revenue

ACI Formulations had revenue of 1.30B BDT in the quarter ending March 31, 2025, with 5.39% growth. This brings the company's revenue in the last twelve months to 5.01B, up 0.65% year-over-year. In the fiscal year ending June 30, 2024, ACI Formulations had annual revenue of 4.94B, down -0.49%.

Revenue (ttm)

5.01B

Revenue Growth

+0.65%

P/S Ratio

1.20

Revenue / Employee

4.84M

Employees

1,034

Market Cap

6.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.94B	-24.35M	-0.49%
Jun 30, 2023	4.96B	712.39M	16.77%
Jun 30, 2022	4.25B	382.88M	9.91%
Jun 30, 2021	3.86B	440.49M	12.86%
Jun 30, 2020	3.42B	-628.33M	-15.51%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Grameenphone	157.46B
Square Pharmaceuticals PLC.	75.86B
British American Tobacco Bangladesh Company	98.15B
Robi Axiata PLC.	97.75B
Walton Hi-Tech Industries	78.24B
BRAC Bank PLC.	65.27B
Bangladesh Export Import Company	17.72B
Berger Paints Bangladesh	27.70B

Revenue Rankings